Improving Bone Health Among Rheumatoid Arthritis (RA) Patients on Chronic Glucocorticoids

Phase 4

Completed

• Conditions: Adverse Effect of Glucocorticoids and Synthetic Analogues; Osteoporosis; Rheumatoid Arthritis
• Interventions: Other: Storytelling online video

• Registration Number: NCT01378689
• Lead Sponsor: University of Alabama at Birmingham

Brief Summary

This quality improvement project is aimed at improving health care by identifying low cost strategies to get Rheumatoid Arthritis (RA) patients to more effectively communicate with their physicians about osteoporosis prevention and treatment (improving doctor-patient communication). The investigators will implement a direct to patient intervention to the population of interest (patients on chronic glucocorticoids) via story-telling, using an Internet based video. The target audience is people on chronic glucocorticoids not already receiving bones-specific osteoporosis medications to determine differences in post-intervention rates of osteoporosis care, and the rates of prescription anti-osteoporosis therapies.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-09
• Study First Submitted: 2011-06-16
• Study First Submitted QC: 2011-06-20
• Study First Posted: 2011-06-22
• Primary Completion: 2012-03
• Study Completion: 2012-12
• Status Verified: 2013-01
• Last Update Submitted: 2013-01-14
• Last Update Posted: 2013-01-16

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 4659

Inclusion Criteria

• Greater than or equal to 5 milligrams of prednisone or glucocorticoid dose equivalent for greater than or equal to 90 days within the previous 12 months
• Medco member for entire study period
• Refill steroid prescription online

Exclusion Criteria

• anti-osteoporosis medication in previous 12 months

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Online video	Storytelling online video	Participants in this arm are shown a brief video (\~5 minutes) after ordering a refill for their glucocorticoid use. The video includes real patients telling their own story about the possible side effects of prolonged use of glucocorticoids.

Primary Outcome Measures

Name	Time	Method
Number of participants receiving Anti-osteoporosis Treatment	within 3 - 12 months of exposure to video	Includes bisphosphonates, PTH, SERM, Calcitonin

Secondary Outcome Measures

Name	Time	Method
Calcium and Vitamin D use	within 3 - 12 months of exposure to video	Are participants taking calcium and vitamin d supplements
Patient-Physician Communication	within 3 - 12 months of exposure to video	Did viewing the video increase patient-physician communication

Trial Locations

Locations (1)

University of Alabama at Birmingham; 🇺🇸 Birmingham, Alabama, United States